Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jun 14, 2024

BUY
$2.7 - $3.32 $456,329 - $561,116
169,011 Added 101813.86%
169,177 $524,000
Q3 2023

Oct 10, 2023

BUY
$2.7 - $3.32 $456,329 - $561,116
169,011 Added 101813.86%
169,177 $524,000
Q1 2023

Jun 14, 2024

BUY
$1.43 - $2.86 $237 - $474
166 New
166 $0
Q3 2022

Nov 10, 2022

SELL
$0.17 - $5.25 $821 - $25,378
-4,834 Reduced 96.68%
166 $0
Q4 2021

Feb 28, 2022

BUY
$0.34 - $1.0 $1,700 - $5,000
5,000 New
5,000 $2,000

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0

About CohBar, Inc.


  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.19M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.